Merck & Co., Inc. (6MK.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 264.66B |
| Enterprise Value | 301.41B |
| P/E Ratio | 121.07 |
| PEG Ratio | -1.5 |
| Price/Sales Ratio | 5.67 |
| Price/Book Ratio | 8.99 |
| Enterprise/Revenue | 6.38 |
| Enterprise/EBITDA | 30.61 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.17 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 65.02B |
| Revenue/Share | 26.86 |
| Gross Profit | 52.99B |
| EBITDA | 28.26B |
| Net Income | 18.26B |
| Diluted EPS | 7.28 |
Balance Sheet
| Total Cash | 7.14B |
| Total Cash/Share | 2.89 |
| Total Debt | 53.91B |
| Total Debt/Equity | 1.29 |
| Current Ratio | 1.32 |
| Book Value Per Share | 16.98 |
Price History
| 52-Week Change | 76.8 |
| 52-Week High | 132.22 |
| 52-Week Low | 66.4 |
| Moving Average 50 Days | 111.05 |
| Moving Average 200 Days | 99.93 |
Statistics
| Average Volume | 1,763 |
| Shares Outstanding | 2.47B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.36 |
| Trailing Annual Dividend Yield | 2.2 |
| Payout Ratio | 2.62 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
